Fig. 2From: ADAM15 expression is increased in lung CD8+ T cells, macrophages, and bronchial epithelial cells in patients with COPD and is inversely related to airflow obstructionSoluble ADAM15 (sADAM15) levels in bronchoalveolar lavage fluid (BALF) and plasma samples from patients with chronic obstructive pulmonary disease (COPD), smokers, and non-smokers. a: Soluble ADAM15 (sADAM15) protein levels were measured in BALF samples from non-smokers (n = 6), smokers (n = 19), and patients with COPD (n = 14) using an ELISA kit. The boxes in the box-plots show the medians and 25th and 75th percentiles, and the whiskers show the 10th and 90th percentiles. Data were analyzed using a Kruskal-Wallis One-Way ANOVA followed by pair-wise testing with Mann-Whitney U tests. b: sADAM15 protein levels were measured in plasma samples from non-smokers (n = 28), smokers without COPD (n = 27), COPD patients with GOLD stage I-II disease (n = 27), and COPD patients with GOLD stage III-IV disease (n = 33) using an ELISA kit. The boxes in the box-plots show the medians and 25th and 75th percentiles, and the whiskers show the 10th and 90th percentiles. Data were analyzed using a Kruskal-Wallis One-Way ANOVA followed by pair-wise testing with Mann-Whitney U testsBack to article page